Literature DB >> 6867724

Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid.

R E Becker, C Giambalvo, R A Fox, M Macho.   

Abstract

Inhibitory activity against the enzyme monoamine oxidase is present in low molecular weight fractions (less than 100,000) of human cerebrospinal fluid. These endogenous substances of different molecular weights (3000 to more than 35,000) act like monoamine oxidase inhibitor drugs to inhibit both type A and type B monoamine oxidase.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6867724     DOI： 10.1126/science.6867724

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  6 in total

1.  Potentiation by deprenyl of the autoreceptor-mediated inhibition of [3H]-5-hydroxytryptamine release by 5-methoxytryptamine.

Authors:  A M Galzin; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

Review 2.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

3.  Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes.

Authors:  S Murphy; A Pastuszko
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

4.  Purification and characterization of tribulin, and endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding.

Authors:  J D Elsworth; D Dewar; V Glover; B L Goodwin; A Clow; M Sandler
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Variations in the monoamine oxidase-inhibitory activity ("tribulin?") in pig's urine.

Authors:  D F Sharman; D B Stephens; G Cohen; M Holzbauer
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

6.  The stress-induced reduction in monoamine oxidase (MAO) A activity is reversed by benzodiazepines: role of peripheral benzodiazepine receptors.

Authors:  I Armando; A P Lemoine; E T Segura; M B Barontini
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.